ConductScience.org, home

Paper · 42657191

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131355696A smart drug-delivery nanosystem based on carboxylated graphene quantum dots for tumor-targeted chemotherapy.Nanomedicine (Lond)2019https://conductscience.org/library/papers/31355696PubMed
238745193Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.J Nanobiotechnology2024https://conductscience.org/library/papers/38745193PubMed
334866166Nanoparticles for Cancer Therapy: Current Progress and Challenges.Nanoscale Res Lett2021https://conductscience.org/library/papers/34866166PubMed
436883982Graphene family in cancer therapy: recent progress in cancer gene/drug delivery applications.J Mater Chem B2023https://conductscience.org/library/papers/36883982PubMed
532992117Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem.Biomaterials2021https://conductscience.org/library/papers/32992117PubMed
627547843Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?Bioconjug Chem2016https://conductscience.org/library/papers/27547843PubMed
738529035Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials.Front Neurol2024https://conductscience.org/library/papers/38529035PubMed
829928344Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway.Oncol Lett2018https://conductscience.org/library/papers/29928344PubMed
93521429Mitoxantrone: a new anticancer drug with significant clinical activity.Ann Intern Med1986https://conductscience.org/library/papers/3521429PubMed
1038572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1140563442Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery.Biomolecules2025https://conductscience.org/library/papers/40563442PubMed
1226286294Mitoxantrone, More than Just Another Topoisomerase II Poison.Med Res Rev2016https://conductscience.org/library/papers/26286294PubMed
1335965519Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action.Front Oncol2022https://conductscience.org/library/papers/35965519PubMed
1433370092Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation.J Am Chem Soc2021https://conductscience.org/library/papers/33370092PubMed
1537566091Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy.Cells2023https://conductscience.org/library/papers/37566091PubMed
1635008083Construction of an exosome-functionalized graphene oxide based composite bionic smart drug delivery system and its anticancer activity.Nanotechnology2022https://conductscience.org/library/papers/35008083PubMed
1728883419Bio-fabrication of silver nanoparticles by phycocyanin, characterization, in vitro anticancer activity against breast cancer cell line and in vivo cytotxicity.Sci Rep2017https://conductscience.org/library/papers/28883419PubMed
1841174009Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer.Nat Biomed Eng2026https://conductscience.org/library/papers/41174009PubMed
1939370518Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.J Nanobiotechnology2024https://conductscience.org/library/papers/39370518PubMed
2029457592PEGylated graphene oxide/Fe3O4 nanocomposite: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem.Biomed Mater Eng2018https://conductscience.org/library/papers/29457592PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/42657191/references